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The ability of fresh serum to opsonize microorganisms was recognized nearly 70 yr 
ago  (1).  Subsequent  studies identified synergistic effects of both antibody and com- 
plement on opsonizatiou (2) and demonstrated that particles to which C3 was affixed 
by the sequential participation of antibody, C1, C4, and C2 became opsonized (3-6). 
In 1968, a patient was found with marked susceptibility to infection who spontaneously 
inactivated C3 in vivo. His serum had normal functional levels of antibody, CI, C4, 
and  C2,  but  failed  to  opsonize bacteria  even  when  fortified with  purified  C3  (7). 
Further studies of his serum revealed a  defect in his properdin pathway  (8,  9). This 
patient, and the good health of humans deficient in C2 (10) and of guinea pigs deficient 
in C4 (~ 1), have emphasized the functional significance of this alternate pathway of C3 
activation, first recognized by Pillemer and his associates (12).  The properdin system 
has been shown to participate in bacteriolysis,  protozoal inactivation, virus neutraliza- 
tion,  and  lysis  of  erythrocytes  in  paroxysmal nocturnal  hemoglobinuria  (13-16). 
Unlike the classical complement pathway, the properdin system can be activated by 
polysaccharides in the absence of antibody (17). 
This  report  describes  quantitative  studies  of  the  phagocytosis  of  paraffin 
oil  droplets  coated  with  bacterial  lipopolysaccharide. Opsonization  of  these 
particles occurs in the absence of C4 and C2, but is dependent upon C3 and the 
properdin pathway.  Measurement  of  the  opsonization  of  these  particles thus 
constitutes a  quantitative functional assay for this system. 
Materials and Methods 
Preparation of Phagocytes.--Suspensions containing  over 95%  polymorphonuclear  leuko- 
cytes were  obtained from  guinea  pig peritoneal exudates.  The exudates  were elicited  with 
sodium  caseinate,  and  the  cells were  collected  and  washed  as previously described  (18). 
Human peripheral blood from normal laboratory personnel  or patients with infections  and 
leukocytosis was collected with acid-citrate dextrose, National Institutes of Health formula A; 
the erythrocytes were removed by dextran sedimentation  and lysis with ammonium chloride; 
and leukocytes were washed as described previously  (19). The celts were suspended in Krebs- 
Ringer  phosphate medium,  pH 7.4  (medium),  at  a  concentration  of 2-5 mg of guinea  pig 
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granulocyte protein/ml or 1.5-6.0 X  107 human leukocytes/ml, of which 70-95% were phago- 
cytes  (polymorphonuclear leukocytes, band forms, and monocytes). Cellular protein was de- 
termined by the Folin method  (20),  and cells were enumerated with an electronic counter 
(Coulter Electronics, Inc., Hialeah, Fla.) 
Serum and Purified Serum Proteins.--Guinea pig blood was collected by cardiac puncture 
and human blood, by venipuncture. The serum was separated and maintained at 0°C until 
used in experiments or stored at --70°C. Serum of guinea pigs genetically deficient in C4 (11) 
was a  gift of Dr. Leonard Ellman. Serum was obtained from individuals whose serum con- 
tained less than 1% of the normal C2 concentration (10), from patients with hereditary angio- 
neurotic edema (HANE) ~ during acute attacks (whose serum contained less than 1% of nor- 
mal C6 and C2 (21), from a patient with hereditary deficiency of C3 (22), from a patient with 
type I hypercatabollsm of C3  (7), and from cord blood of full-term newborn infants, some of 
which were  deficient in  glycine-rieh beta-glyeoprotein  (GBG)  (23).  In  some  experiments, 
human serum was treated with zymosan, 70 mg/ml, or hydrazine, 0.03 M, or heated for 30 
rain at 56°C.  GBG, factor B of the properdin system, or the C3 proactivator (24) was purified 
from normal human serum as described previously (25).  C3 was prepared by the method of 
Nilsson and Mfiller-Eberhard (26). C3 was labeled with 125I by the iodine monochloride tech- 
nique (27).  C4, C2, C3, and GBG were measured by electroimmunoassay (28). 
Lipopolysaccharide  Particles.--Lipopolysaccharide,  prepared by extraction with trichloro- 
acetic acid and ethanol precipitation (29) from Escherlchia  coli O26:B6, was purchased from 
Difco Laboratories, Detroit, Mich. It was used as received or after the treatments described 
below: 
(a) 100 mg of the lipopolysaccharide was suspended for 12 h in 40 ml of chloroform-metha- 
nol (2:1) at 4°C and centrifuged. After 12 h, the lipopolysaccharide was collected by eentfifu- 
gation and dried under N2. 
(b) 30 mg of the lipopolysaccharide was suspended for 15 rain at  37°C  in 2  ml of fresh 
human serum and then washed and collected twice by sedimentation through 10 ml of 2% 
bovine serum albumin in 0.15 M NaCI and twice through 0.15 M NaCI at 100,000 g (max) for 
30 rain. 
(c) The lipopolysaecharide was acetylated  (30) or deacylated with pyridine-formic acid or 
BF~-methanol (31). 
Emulsions of paraffin oil containing oil red O were prepared as previously described  (32). 
30 mg of the lipopolysaccharide was suspended in 3 ml of medium and dispersed by sonication 
for 5 s. 1 ml of heavy paraffin oil containing oil red O (32) was layered over the lipopolysaccha- 
ride suspension and emulsified by sonication for 45 s. 
Lipopolysaccharide  Immune  Serum.--Antibody  to  lipopolysaccharide  was  prepared  by 
injecting 0.2 ml of lipopolysacchafide particles into rabbits intravenously every other day for 
7 days. 3 wk later another injection was administered, and 7 days thereafter the rabbits were 
bled.  This serum and  serum flora  untreated  rabbits were heated at  56°C  for 30 min. The 
immune serum, but not the control serum, yielded precipitin lines with the lipopolysaceharide 
on double diffusion in agarose gel. It contained 941/~g of antibody protein/ml. 
Opsonization.--Unless  indicated  otherwise,  the  particles  were  opsonized  before  being 
added  to the cells.  Thus, the measured rate of ingestion was not influenced by the rate of 
opsonization. In all instances, homologous serum was used. In most experiments with guinea 
pig granulocytes, serum was incubated with lipopolysaccharide particles  (0.3  ml serum/0.7 
ml of particles) for 15 rain at 37°C.  In most experiments with human leukocytes, 0.5 ml of 
human serum was incubated with an equal volume of particles.  In some experiments, the 
particles were washed after opsonization. The washing was accomplished by centrifugation 
1  Abbreviations  used in this paper:  GBG, glycine-rich beta-glycoptotein; HANE, hereditary 
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at 100,000  g (max) for 30 rain, aspiration of the infranatant fluid from the pellicle of particles, 
and resuspension of the particles in fresh medium. For investigation of the effect of divalent 
cations on ingestion, the particles were dialyzed after opsonization, first against 1 mM EDTA, 
pH 7.0, in 0.15 M NaCI, and then against 0.13 M  NaC1 and 15 mM sodium phosphate, pH 7.4. 
Fixation of [125I]C3 to  Lipopolysaccharide  and  Lipopolysaccharide  Partides.--125I-labeled 
C3, specific activity 6  )< 104-3  X  105 cpm/#g, was added to fresh human serum or heat-inac- 
tivated human serum (final activity 2.1  X  10 a cpm/ml). Lipopolysacchafide or lipopolysac- 
eharide particles were incubated with the serum so that the final lipopolysaccharide concentra- 
tion was  15  mg/ml of serum, and then washed with albumin and NaC1  as described above. 
Radioactivity of the lipopolysaccharide or lipopolysaccharide particles was determined with a 
Packard Auto-Gamma spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). 
Incubations.--The  rate of ingestion of paraffin oil red O particles by leukocytes was meas- 
ured  as previously described  (32).  Briefly, lipopolysaccharide particles were incubated with 
polymotphonuclear leukocytes in  medium  at  37°C.  At  zero time and  appropriate  intervals 
thereafter, uningested particles were removed from the cells by differential centfifugation in 
0.15 M  NaCI containing 1 mM N-ethyl-maleimide at 150 g, and the oil red O content of diox- 
ane extracts of the cell pellets was measured spectlophotometricaily at 525  nm as previously 
described (32).  Zero time values were zero in this system, and differences between duplicate 
samples at all times ~ere less than 5%. 
RESULTS 
Assay  of Ingestion  of Lipopolysaccharide  Particles  by  Guinea  Pig Granulo- 
cytes.---As  shown in Fig. 1, when opsonized particles in the usual concentration 
were added  to granulocytes, ingestion began immediately and continued  at a 
constant  rate for about 6  rain. The rate of ingestion was not  increased when 
the particle concentration was doubled. Particles not treated with serum were 
ingested  at  a  rate  less  than  10%  of  that  of opsonized  particles.  When  ceils, 
unopsonized  particles,  and  guinea pig  serum were  incubated  simultaneously, 
rapid ingestion was achieved only after 4 rain, presumably the  time required 
for opsonization. No detectable ingestion of opsonized particles occurred during 
incubation with cells for 10 rain in the presence of i  mM N-ethvl-maleimide or 
at 0°C. Similar results were obtained with human serum (19). 
Maximal opsonization was produced with 0.03 ml of guinea pig serum/rag of 
lipopolysaccharide  (Fig.  2,  inset).  As shown in  Fig.  2,  the  stimulatory effect 
of serum on the initial rate of ingestion was not significantly decreased by pro- 
longed dialysis against 0.15 M  NaCI at 4°C. It was abolished if the serum was 
heated  (56°C  for 30  rain),  incubated  with  zymosan, hydrazine,  or EI)TA  (2 
mM). Serum, hydrazine, and EDTA were removed from the particles by wash- 
ing in these experiments. 
Efl'ect of Divalent  Cations  on the Ingestion  of Lipopolysaccharide  Particles by 
Guinea  Pig Granulocytes.--Fig.  3  shows that opsonized and dialyzed particles 
were  ingested  by  guinea  pig  granulocytes  in  the  absence  of  added  divalent 
cations.  Addition  of Ca  ++  or Mg  ++  to  the  incubation  medium  at  concentra- 
tions of less than  1 mM caused a  small but reproducible increase in  the rates 
of ingestion,  whereas concentrations  greater than  1 mM  were slightly inhibi- 
tory.  In  medium  without  added  divalent  cations,  1 mM  EDTA  completely 
inhibited  particle uptake  (Table I). T.  P.  STOSSEL, C.  A.  ALPER,  AND  F.  S.  ROSEN  693 
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FIG.  |.  Ingestion of 1~. coli lipopolysaccharide  particles by guinea pig granulocytes. The 
experiment was performed with six flasks, each containing 15.6 mg of cell protein. All flasks 
wele incubated for 10 rain with gentle shaking before addition of particles. Flask 1 (El) con- 
tained cells in 4 ml of medium and was maintained at ice bath temperature. 1 ml of particles 
opsonized with fresh serum was added at zero time. All other flasks were kept at 37°C. Flask 
2 (I) contained ceils in 4 ml of medium with 1 mM N-ethyl-maleimide. Opsonized  particles 
(1 m]) were added at zero time. Flask 3 (O) contained cells in 4 ml of medium. 1 ml of par- 
ticles  previously treated  with medium rather than serum was added at zero  time. Flask 4 
(0) contained cells in 4 ml of medium fortified with fresh guinea pig serum (20% by volume). 
Particles  (1 ml) treated with medium rather than serum were  added at zero  time. Flask 5 
(~) contained cells in 4 ml of medium. 1 ml of particles opsonized with fresh serum was added 
at zero time. Flask 6 (A) contained cells in 3 ml of medium. Opsonized particles (2 ml) were 
added at zero time. Samples were taken from all flasks for washing and oil red O analysis at 
zero time and at the other times indicated. 
Trealment  of Lipopolysaccharide  Particles  after  Opsonization  by Guinea  Pig 
Serum.--Aher  opsonization, the  lipopolysaccharide particles could be washed 
repeatedly  with  salt  solutions  of  different  concentrations,  heated  (56°C,  30 
rain), and even boiled for  15  rain without significant loss of ingestibility (Fig. 
4).  They  could  also  be  frozen  (-20°C),  thawed,  and  resonicated  without 
diminution of the rate with which they were ingested. 
Effect of C4-Deficient Guinea Pig Serum on the Ingestion of Lipopolysaccharide 
Particles  by  Guinea Pig  Granulocytes.--Lipopolysaccharide  particles  treated 
for 15 ruin at 37°C with C4-deficient guinea pig serum were ingested as rapidly 
as those incubated with normal guinea pig serum (Table II). The rate,  as well 
as the extent, of opsonization by the C4-deficient serum was normal (Fig. 5). 
E ffecl of Divalent Cations  on the Opsonic Activity of Human Serum.--Human 
serum did not opsonize lipopolysaccharide particles after dialysis against EDTA 
and NaC1  (Table III).  Opsonic activity was  restored  by addition of divalent 
cations.  Magnesium  was  more  effective  than  calcium,  but  both  magnesium 
and calcium were  required  to  obtain opsonic  activity equal  to  that  of undia- 
lyzed  serum.  If  the  particles  were  not  dialyzed  against  EDTA  and  NaC1 694  SERUM-DEPENDENT  PHAGOCYTOSIS 
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FIc.  2.  Effect of guinea pig serum concentration on the rates of ingestion of E. coli lipo- 
polysaccharide particles  by guinea pig polymorphonuclear leukocytes. The bars indicate the 
initial  rate  of  ingestion  by  guinea pig granulocytes  of  E.  coli  lipopolysaccharide  particles 
opsonized with serum  treated  as indicated  and designate  the mean and  range  of  duplicate 
determinations.  All flasks contained  11.2  mg of cell protein in 4  ml of  medium.  Cells were 
incubated for  I0 min before  addition of 1 rnl of particles as described  in Fig.  1. Samples were 
taken for washing and oll red O analysis  at zero time  and  at 4 rain.  (Inset)  This  emulsion 
was prepared  as described  in the text, except that 50 mg of ]ipopolysaccharide was suspended 
in 3 ml of medium. E. coli lipopolysaccharide emulsion, 0.7  ml, was opsonized with 0.3  ml of 
serum or serum diluted with medium. The points are means of duplicate determinations. 
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FI6.  3.  Effect  of  Mg  ++  and  Ca  ++  on  the  initial  rate  of  ingestion  of  opsonized  E.  coli 
ipopolysaccharide  particles  by guinea pig  granulocytes.  The  cells  were  washed  twice with 
0.15 M  NaCI and suspended in 0.13 M  NaC1  containing 15 mM sodium phosphate, pH 7.4, 
and divalent cations as indicated. Opsonized particles, dialyzed as described  in the text, were 
added at zero time, and the initial rate of ingestion was determined as described  in Fig.  2. 
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TABLE  I 
Eject of Divalent Cations and EDTA on Ingestion of Opsonizecl Lipopolysaccharide Particles by 
Guinea Pig Granulocytes 
Divalent cation composition of buffer  Initial rate of ingestion 
No divalent cations  0.090 
CaCI2 (1 raM)  0.110 
MgCI2 (1 raM)  0.121 
MgC12 (1 mM)~ 
CaCl2  (1 mM) )  0.116 
No divalent cations ~  EDTA (1 raM)  0.000 
Cells were washed  twice with  0.15  M  NaCl and  suspended  in  0.13  M  NaC1  containing 
15  mM sodium phosphate,  pH  7.4. The particles were dialyzed against  EDTA and  NaCI 
as described in  the text.  All reagents were prepared  with deionized water.  Particles  (1  ml) 
were added  to granulocytes in 4 ml of medium at zero time. Samples (1  ml) were taken at 
zero time and  at  4  min  from  duplicate  incubations  to  assay  the initial rate  of ingestion. 
The ingestion rate is expressed as milligrams paraffin oil per milligram protein per minute. 
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Fro.  4.  Effect of heat and NaC1 on the ingestibility of opsonized  E. cdi lipopolysaccharide 
particles by guinea pig granulocytes.  The particles were opsonized,  washed,  or heated,  and 
then  divided into  two portions.  One portion  (darker  bars)  was  opsonized  again with fresh 
serum, and  the other was incubated with medium alone  (lighter bars).  The particles  (1  ml) 
were added  to flasks  containing cells  (12 mg protein)  in 4 ml of medium. The initial rate of 
ingestion of particles was determined  as described in Fig.  2.  The  bars  represent  the mean; 
and the lines, the range of values from duplicate incubations. 
before opsonization,  no  apparent  requirement  for divalent  cations by dialyzed 
serunl was detectable. 
Opsonic Activity of Human Serum Deficient in  Various Complement Proteins.- 
The opsonic activities of sera from two patients  with hereditary  C2 deficiency 
and from five patients  with HANE  without  demonstrable  hemolytic C2 or C4 
were indistinguishable from those of normals  (Table IV and Fig. 6). 
Some  human  cord  sera  have  subnormal  GBG  levels.  Although  most  cord 
sera  tested  with  the  lipopolysaceharide-paraffin  oil  system  had  decreased  op- 696  SERUM-DEPENDENT  PHAGOCYTOSIS 
TABLE  II 
E~ect  oj Normal Guinea  Pig Serum and  C4-Deficient  Guinea  Pig Serum on the Initial Rate  of 
Ingestion  of Lipopolysaecharlde  Particles  by Guinea  Pig Granulocytes 
Initial rate of ingestion 
Serum source  ............. 
Exp.  t  Exp.  2  Exp.  3 
Normal guinea pig  0.112  0.124  0.096 
C4-de~cient guinea pig  0.115  0.125  0.094 
E.  coli lipopolysaccbaride particles were opsonized with serum as described in the  text 
The conditions of incubation and analysis of ingestion were essentially as described in Table 
I. The means of values from duplicate incubations in three experiments are shown. 
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sonic activity, those with diminished amounts of  GBG had even less opsonic 
capacity than those with normal GBG. The addition of purified GBG to GBG- 
deficient cord serum increased its opsonic activity (Fig.  7).  This cord  sermn 
had  a  C3  concentration of  1,200 nag/liter, i.e.,  within the normal range. The 
serum of a  child with hereditary C3 deficiency failed to opsonize the lipopoly- 
saccharide emulsion. As shown in Fig. 8,  addition of purified C3  to the serum 
of this patient restored opsonic capacity. However, addition of purified C3  to 
the serum of a patient with hypercatabolism of C3 was without effect. 
The initial rate of ingestion of lipopolysaccharide particles by human leuko- 
cytes  was  reproducibly increased  15-30%  by  incubating the  particles  with 
heated  lipopolysaccharide  immune serum  (0.4  mg  antibody protein)  before 
opsonization  with  fresh  normal  serum,  C2-deficient  serum,  or  cord  serum 
deficient in GBG (Table V). 
FIG. 5.  Rate of opsonization of E. coli lipopolysaccharide particles by normal and by C4- 
deficient guinea pig serum. Normal guinea pig serum (O)  or C4-deficient guinea pig serum 
(I)  was incubated  with  lipopolysaccharide particles at  37°C for the  time indicated.  The 
incubations were terminated by addition of 10 vol of ice-cold 0.15 M NaC1 containing 1 mM 
EDTA. The particles were washed and added in 1 ml volumes to flasks containing guinea pig 
granulocytes (13.2 mg of cell protein) in 4 ml of medium. The initial rate of ingestion was 
determined from samples taken at zero time and at 4 min. Each point designates the mean of 
determinations from duplicate flasks. T.  P.  STOSSEL~ C.  A.  ALPER,  AND  ~F.  S.  ROSEN  697 
TABLE III 
Effect of Divalent Cations on the Opsonization of Lipopolysaccharide Particles by Fresh Human 
Serum 
Divalent cations added to dialyzed  serum  Initial rate of ingestion 
None  0.029 
CaCI2, 5 mM  0.284 
MgCI2, 5 mM  0.345 
CaC12, 5 mM l 
MgCI2, 5 mMJ  0.444 
Undialyzed Serum  0.455 
Human serum was dialyzed against 0.15  M  NaCI-10 mM phosphate buffer, pH  7.4, and 
used to opsonize lipopolysaccharide particles. The particles were dialyzed against EDTA and 
NaCl as described in the text before opsonization. After opsonization, the particles (0.4 ml) 
were  washed  free  of serum  and  then  suspended  in  Krebs-Ringer phosphate  medium  and 
added to 2.4 )<  107 human leukocytes in 1.6 ml of medium. Samples (0.5 ml) were taken at 
zero time and at 4 rain from duplicate incubations to assay the initial rate of ingestion. The 
ingestion rate is expressed  as milligrams paraffin oil per 107 phagocytes per minute. 
TABLE  IV 
Effect  of Normal  Human  Serum,  C2-Deficient Human Serum,  and  Hereditary Angioneurotic 
Edema Serum on the Initial Rate of Ingestion of Lipopolysaccharide Particles 
by Human Leukocytes 
Serum source  Initial rate of ingestion 
Normal  0.204  ±  0.044* 
C2-deficient 
Patient  1  0.196 
Patient 2  0.215 
Hereditary angioneurotic edema 
Patient 1  0.211 
Patient 2  0.178 
Patient 3  0.192 
Patient 4  0.169 
Lipopolysaccharide particles  were  opsonized  with  equal  volumes of the  indicated  sera. 
The conditions of incubation and analysis of ingestion were those described in Table III. 
* Mean ±  SD; N  =  82. 
Treatment of Lipopolysaccharide  before Preparing Particles.--Table VI shows 
that  particles  made  from  lipopolysaccharide  that  had  been  extracted  with 
chloroform-methanol  fixed more  [~25I]C3 in the presence of fresh human  serum 
and  were  ingested  more  rapidly  after  opsonization  than  native  lipopolysac- 
charide particles. Deacylation or acetylation of the lipopolysaccharide rendered 
particles  prepared  from it unsuitable  for  opsonization.  To  assess  whether  the 
lipopolysaccharide  could  be  opsonized  before  preparation  of  the  particles, 
lipopolysaccharide  was  incubated  with  serum  containing  [125I]C3 and  washed 
by  sedimentation  in  albumin  and  NaC1  solutions.  The  lipopolysaccharide 698  SERUM-DEPENDENT  PHAGOCYTOSIS 
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FIG.  6.  Effect of serum concentration on the opsonic activity of normal (0)  and heredi- 
tary angioneurotic edema (©) serum. E. coli lipopolysaccharide particles were opsonized with 
the indicated concentrations of serum. The initial rate of ingestion of these particles by human 
leukocytes was assayed as described in Table lII. 
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FIG.  7.  Effect of  GBG on the opsonic activity of cord serum.  1'~. coli  lipopolysacchafide 
particles were incubated with heat-inactivated cord serum  (©)  and with fresh Cord serum 
(11)  to which purified  GBG or  appropriate  amounts of 0.15  M  NaC1  diluent were  added. 
The  GBG concentration of the serum without  additions was  100  mg/liter.  The  opsonized 
particles (0.2 ml) were added to 3.4 X  10  7 human phagocytes in 0.8 ml of Krebs-Ringer phos- 
phate medium. The initial rate of ingestion was determined as described in Table III. 
suspended in serum did not bind significant quantities of  [125I]C3.  When  parti- 
cles  were  prepared  from  this  pretreated  material,  they  were  poorly  ingested 
unless incubated with serum. 
DISCUSSION 
Lipopolysaccharide  constitutes  the outer cell wall  of gram-negative bacteria 
(33)  and  forms  a  membranous  structure  when  suspended  in  aqueous  medium T.  P.  STOSSEL~ C.  A.  ALPER~ AND  F.  S.  ROSEN  699 
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FIG.  8.  Effect of C3 on the opsonic activity of serum of a patient with hereditary deficiency 
of C3. E. coli lipopolysaccharide particles were incubated with the patient's serum to which 
purified C3 or appropriate amounts of 0.15 M  NaC1 diluent were added. The rate of engulf- 
ment of the opsonized particles was assayed as described in Table III. 
TABLE  V 
Effect  of Antibody on the Opsonlc Activity of Fresh Homologous Serum for Lipopolysaccharide 
Pa/ticles 
Source of human serum 
Rabbit Serum 
Immune  Normal 
Initial rate of ingestion 
Normal  --  +  0.180 
Normal  +  --  0.230 
Normal, heated 56°C,  30 rain  +  --  0.011 
C2-deficient  --  +  0.169 
C2-deficient  +  --  0. 230 
Cord  --  +  0.102 
Cord  +  --  0.122 
Lipopolysaccharide  particles,  0.4  ml,  were  incubated  with  0.4  ml  of  heat-inactivated 
normal or immune rabbit serum (containing 0.4 mg of antibody protein) for 15 min at 37°C 
and were then washed and resuspended to a volume of 0.4 ml with Krebs-Ringer phosphate 
medium, pH  7.4.  Of the indicated human serum, 0.4 ml was added and the particles incu- 
bated for 15 rain at 37°C.  The opsonized particles were added to phagocytes, and the rate of 
ingestion was assayed as described in Table III. 
(34). The molecule is amphipathic, which presumably  accounts for its effective- 
ness in maintaining  a  stable emulsion of paraffin oil in an electrolyte solution. 
Ingestion of paraffin oil emulsified with E. coli lipopolysaccharide by polymor- 
phonuclear  leukocytes  simulated  the  ingestion  of  the  parent  bacteria  insofar 
as  the  rate  of  engulfment  of  the  particles  was  markedly  stimulated  by  fresh 
homologous serum. The opsonic effect of the serum was found to be exerted on 
the particles and to be resistant to dialysis, labile to heat, hydrazine, and zymo- 7O0  SERUM-DEPENDENT  PHAGOCYTOSIS 
TABLE  VI 
[l~l]C3 Uptake by Lipopolysaecharide Particles 
Initial rate o[ 
ingestion of the  [12~I]C3  bound to 
Treatment of lipopolysaccharlde  Treatment of serum  particles by hu-  the particles 
man leukocytes 
% 
None  56°C, 30 rain  0.011  1.3 
None  None  0. 266  6.1 
Chloroform-methanol-extracted  56°C, 30 min  0. 015  1.0 
Chloroform-methanol-extracted  None  0.4.52  9.5 
Particles  were prepared  with  untreated  or  chloroform-methanol-extracted lipopolysac- 
charide, suspended in the indicated human sera, washed, assayed for radioactivity and then 
for ingestibility by human leukocytes as described in the text. 
san,  and  dependent  upon  temperature  and  divalent  cations.  These  findings 
were  consistent  with  observations  implicating  complement  or  complement- 
like agents as the heat-labile opsonins of serum (2-6,  35).  Further pursuit  of 
the nature of the opsonic process delineated  the role of C3  and the properdin 
system, but  not  of the  classical  complement pathway in  the  opsonization of 
lipopolysaccharide particles.  First,  C4-  and  C2-deficient  serum from humans 
and guinea pigs had normal opsonic activity for the lipopolysaccharide parti- 
cles.  Similar findings were previously reported with respect to the opsonization 
of various bacterial species by C4- and C2-deficient HANE serum by Stoller- 
man  and  co-workers (36)  and by genetically C2-deficient serum by Johnston 
and his  colleagues  (4).  These observations were recently confirmed with  sera 
deficient  in  Clq,  C4,  or  C2  (37-39).  Secondly,  the  opsonic  activity  of  cord 
serum deficient in  GBG or factor B  of  the properdin  system was subnormal 
and was enhanced by addition of purified GB G (40). Finally, addition of purified 
C3  to the serum of a  patient with hereditary absence of C3 but with normal 
GBG restored opsonic activity to  that serum in proportion  to  the  amount of 
C3  added.  On  the  other  hand,  addition  of  C3  to  the  serum  of  the  patient 
with t~3~e I  essential hypercatabolism of C3 did not have this effect. This pa- 
tient has normal properdin but no properdin factor B activity and absent GBG, 
and has normal levels of C2 and C4 (6, 7). Absence of an inhibitor of the proper- 
din system, the C3 inactivator, has been shown to be responsible for a lack of 
GBG in this patient's serum, which secondarily results in deficient complement- 
mediated functions (41). However, enrichment of this patient's serum with puri- 
fied C3 inactivator,  GBG, and C3  does not  enable it to opsonize, which indi- 
cates  that  this  serum is  deficient  in  yet  other  constituents  of  the  properdin 
system which are incompletely understood.  Nevertheless, all of these findings 
indicate  that the lipopolysaccharide particles activate C3  in normal serum by 
means of  the  properdin  system.  Therefore,  measurement of  the  opsonization 
of these particles comprises a  functional  assay for this pathway. With  intact T.  P.  STOSSEL,  C.  A.  ALPER,  AND  ~F.  S.  ROSEN  701 
bacteria as the test particle, bactericidal activity of serum may be exerted by 
reactions of the properdin system, the classical  complement sequence, or both, 
the latter predominating if an excess of antibody is present (10). This fact prob- 
ably explains why it was possible to observe normal opsonization of pneumo- 
cocci  by sufficient quantities of C2-deficient serum.  Even in  the presence of 
immune  serum  to  lipopolysaccharide,  C2-  and  C4-deficient  sera  promoted 
rates of ingestion of lipopolysaccharide particles equivalent to that provided 
by normal  sera.  Furthermore,  GBG-deficient cord  serum  containing normal 
concentrations of C2  and C4 did not acquire normal opsonic activity by the 
addition of antibody to  lipopolysaccharide. The  lipopolysaccharide particles 
thus  appear  to  have  an  absolute  dependence  on  the  properdin  system for 
opsonization. 
Some previous  studies of the properdin  system indicated that magnesium 
but not calcium was required for the activity of this pathway (15). In the pres- 
ent  investigation,  both  ions  were  necessary for  optimal  opsonic  activity of 
dialyzed serum,  although magnesium alone was more  effective than calcium 
alone. It is noteworthy that no divalent cation requirement could be demon- 
strated unless the lipopolysaccharide particles were first dialyzed against EDTA 
and  NaC1,  which  presumably removed loosely bound  divalent  cations.  The 
apparent absence of a divalent cation requirement for the heat-labile opsoniza- 
tion of intact bacteria described in an earlier report  (35)  may have resulted 
from such contamination. 
Opsonization by means of the classical  complement sequence has an abso- 
lute dependence on antibody (3-5).  The requirement for antibody in the ac- 
tivation of C3 by means of the properdin pathway remains to be determined. 
Agammaglobulinemic serum  has  heat-labile  opsonic  activity  (42);  although 
relative to normal serum, this activity may be slightly diminished (19). Anti- 
body  to  lipopolysaccharide increased  the  opsonic  capacity  of  fresh  human 
serum in this study. Antibody may enhance, but not be essential for, opsonic 
activity mediated by the properdin mechanism. 
Complex polysaccharides, including lipopolysaccharides, activate the proper- 
din system (17);  and, therefore, it is not surprising that the lipopolysaccharide 
particles  become  opsonized  by  means  of  that  pathway.  The  way in  which 
lipopolysaccharide particles  initiate  properdin  activation  is  not  known,  al- 
though the importance of primary structure for the biologic activity of lipo- 
polysaccharide has been illuminated by studies in which chemical modifications 
of  lipopolysaccharide  resulted  in  loss  or  diminution  in  endotoxic  potency. 
Diverse  treatments,  such  as  acetylation  (30),  alkaline  hydrolysis (43),  and 
deacylation (31), have been shown to diminish mouse lethality and complement- 
converting ability of lipopolysaccharide without destroying antigenicity. Such 
treatment also  appears  to  compromise the  capacity of lipopolysaccharide to 
activate  the  properdin  system.  Particles  prepared  from  lipopolysaccharide 
extracted with chloroform-methanol had normal resistance to ingestion before 702  SERUM-DEPENDENT  PI~.GOCYTOSIS 
opsonization, but  fixed greater  amounts of  [12~I]C3 and were  engulfed more 
rapidly after opsonization than particles of native lipopolysaccharide. Possibly, 
removal of noncovalently bound, interfering lipid by chloroform-methanol ex- 
posed saccharide groups which interact with properdin. 
In many experiments it was necessary to wash the particles,  and this pro- 
cedure did not alter the opsonized state of the particles.  Early studies with 
intact bacteria showed that although serum opsonins were heat labile, the or- 
ganisms, once treated with serum, remained opsonized after heating (2, 44) or 
washing in salt solutions up to 0.67 M  (2, 5, 34, 36, 45). The studies presented 
here  revealed that  the  opsonized state  of the  lipopolysaccharide particles  is 
remarkably  stable,  withstanding  even  boiling.  But  particles  prepared  from 
lipopolysaccharide that had been suspended in fresh serum and then washed 
or repurified were not ingestible without further serum treatment. Although 
there  is  evidence that  lipopolysaccharide suspended in fresh serum  converts 
C3 (46, 47) and that serum produces morphologic changes in lipopolysaccharide 
discernible with the electron microscope (47),  it does not fix  [12aI]C3. There- 
fore,  it  appears  likely that  the  lipopolysaccharide must  be  in  a  particular 
conformation in  order  for  C3  fixation and hence  the  opsonic  interaction  to 
occur. The paraffin oil may provide a  stability and configuration to the lipo- 
polysaccharide that is  similar  to  that of lipopolysaccharide on  the  bacterial 
surface and is required for opsonization. 
The mechanism by which opsonization accelerates the rate of ingestion of 
particles by phagocytes remains to be determined. Earlier studies showed that 
there was an absolute requirement for added divalent cations in order for albu- 
min-coated paraffin oil particles to elicit ingestion by guinea pig granulocytes 
(32).  In this study, added Ca  ++ or Mg  ++ had relatively little influence on the 
rate  of ingestion of opsonized lipopolysaccharide particles.  EDTA,  however, 
abolished the uptake of the particles, suggesting that divalent cations released 
from the washed cells or bound to the plasma membrane may have been suffi- 
cient to permit ingestion. Evidence that heat-labile opsonin may act by lower- 
ing the concentration of divalent cations required for ingestion is presented in 
another report (48). 
SUMMARY 
Paraffin oil containing oil red O and emulsified with lipopolysaccharide ob- 
tained from Escherichia coli was ingested rapidly by guinea pig polymorpho- 
nuclear  leukocytes or  human peripheral  blood  granulocytes  and  monocytes 
after opsonization by fresh homologous serum. The initial rate of engulfment 
of the particles was spectrophotometrically assayed by determination of cell- 
associated oil red O and reflected the opsonic activity of the serum. This ac- 
tivity was  resistant  to  dialysis but  labile  to  heat,  hydrazine, and zymosan, 
required divalent cations, and was maximal in the presence of Ca  ++ and Mg  ++. 
It was associated with the fixation of [1~5I]C3 to the lipopolysaecharide parti- T.  P.  STOSSEL, C.  A.  ALPER, AND  F.  S.  ROSEN  703 
cles.  Genetically C3-deficient serum had no opsonic activity, and this activity 
was restored  by the  addition  of purified  C3.  Normal  and  C4-deficient  guinea 
pig serum and normal, C2-, and C4-deficient human sera were equally effective 
in  opsonizing  lipopolysaccharide  particles  and  lipopolysaccharide  particles 
sensitized  with  heat-inactivated  lipopolysaccharide  immune  serum.  Cord 
serum deficient  in glycine-rich beta-glycoprotein  (GBG)  (properdin  factor B) 
had  diminished  opsonic activity which  was improved  by addition  of purified 
GBG. Thus, C3 fixation to lipopolysaccharide particles occurs by means of the 
properdin  system,  and  the  opsonization  and  ingestion  of  lipopolysaccharide 
particles  constitutes  a  quantitative  functional  assay of this pathway. 
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